D P Foley

Summary

Affiliation: Erasmus Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet Registry
    D P Foley
    Department of Interventional Cardiology Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 54:25-33. 2001
  2. ncbi request reprint Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up
    B J Rensing
    Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    Eur Heart J 22:2125-30. 2001
  3. ncbi request reprint Stenting with a true bifurcated stent: acute and mid-term follow-up results
    S G Carlier
    Interventional Department, Rotterdam Heart Center, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 47:361-96. 1999
  4. ncbi request reprint The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound
    P W Serruys
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur Heart J 22:1938-47. 2001
  5. ncbi request reprint Spontaneous dissections of all three coronary arteries in a 33-week-pregnant woman
    B J Rensing
    Catheterization Laboratory, Thoraxcenter, University Hospital, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 48:207-10. 1999
  6. ncbi request reprint Sonotherapy, antirestenotic therapeutic ultrasound in coronary arteries: the first clinical experience
    E Regar
    Department of Cardiology, Thoraxcentre, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 60:9-17. 2003
  7. ncbi request reprint Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)
    M A Costa
    University Hospital Dijkzigt, Thoraxcentrum, Rotterdam, The Netherlands
    Circulation 104:2689-93. 2001

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet Registry
    D P Foley
    Department of Interventional Cardiology Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 54:25-33. 2001
    ..With late outcomes at least comparable to the best published results, this stent platform provides safe and effective percutaneous treatment of obstructive coronary artery disease. Cathet Cardiovasc Intervent 2001;54:25-33...
  2. ncbi request reprint Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up
    B J Rensing
    Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    Eur Heart J 22:2125-30. 2001
    ..3 mm(3)and 1.8%, respectively. No edge effect was observed in the segments proximal and distal to the stents. CONCLUSION: Implantation of a sirolimus-eluting stent seems to effectively prevent intimal hyperplasia...
  3. ncbi request reprint Stenting with a true bifurcated stent: acute and mid-term follow-up results
    S G Carlier
    Interventional Department, Rotterdam Heart Center, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 47:361-96. 1999
    ..Cathet. Cardiovasc. Intervent. 47:361-369, 1999...
  4. ncbi request reprint The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound
    P W Serruys
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur Heart J 22:1938-47. 2001
    ..29). CONCLUSION: Oral trapidil 600 mg daily for 6 months did not reduce in-stent hyperplasia or improve clinical outcome after successful Wallstent implantation and is not indicated for this purpose...
  5. ncbi request reprint Spontaneous dissections of all three coronary arteries in a 33-week-pregnant woman
    B J Rensing
    Catheterization Laboratory, Thoraxcenter, University Hospital, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 48:207-10. 1999
    ..This is to our knowledge the first report of antepartum and antemortem diagnosis of pregnancy related coronary dissections in all three coronary arteries. Cathet. Cardiovasc. Intervent. 48:207-210, 1999...
  6. ncbi request reprint Sonotherapy, antirestenotic therapeutic ultrasound in coronary arteries: the first clinical experience
    E Regar
    Department of Cardiology, Thoraxcentre, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 60:9-17. 2003
    ..Sonotherapy-related major adverse events were not observed. Late lumen loss and neointimal growth were similar to conventional PTCA approaches. These results justify the initiation of randomized clinical efficacy studies...
  7. ncbi request reprint Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)
    M A Costa
    University Hospital Dijkzigt, Thoraxcentrum, Rotterdam, The Netherlands
    Circulation 104:2689-93. 2001
    ....